Drugs / ThromboView
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00123734 | Mar 2005 → May 2006 | venous thromboembolism | Agen Biomedical | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ThromboView | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00123734 ↗ |
| Known as | DI-DD3B6/22-80B3 | “Anti-Fibrin Humanized Monoclonal Antibody (DI-DD3B6/22-80B3) Fab' Protein Fragment (ThromboView) Conjugated With Technetium-99m” NCT00123734 ↗ |
| Modality | Monoclonal antibody | “99mTc-labeled monoclonal antibody” NCT00123734 ↗ |
| Route | Intravenous | “intravenous injection” NCT00123734 ↗ |